Elsevier

Cellular Immunology

Volume 128, Issue 2, July 1990, Pages 385-399
Cellular Immunology

Effects of modulators of adenylyl cyclase on interleukin-2 production, cytosolic Ca2+ elevation, and K+ channel activity in Jurkat T cells

https://doi.org/10.1016/0008-8749(90)90035-PGet rights and content

Abstract

We have studied the effects of prostaglandin E2 (PGE2) and cholera toxin, two modulators of adenylyl cyclase, and 8-bromo cAMP (8-BrcAMP) on various parameters of lymphocyte activation using the human T cell line Jurkat. Our results show that PGE2 and cholera toxin inhibit, in a dose-related manner, the phytohemagglutinin (PHA)-dependent production of interleukin 2 by these cells. The data are consistent with the interpretation that the inhibition is due to an intracellular increase in cAMP, since the metabolically stable 8-BrcAMP analog produced the same inhibitory effect. However, PGE2 or 8-BrcAMP did not interfere with the PHA-induced elevation in the cytosolic concentration of Ca2+, suggesting that changes in the intracellular concentration of cAMP does not affect the internal release or the influx of Ca2+. In contrast, cholera toxin prevented the Ca2+ response of Jurkat cells to PHA. We studied the effects of PGE2, cholera toxin, and 8-BrcAMP on the amplitude of the K+ outward current using the patch clamp technique in the whole cell configuration. Results showed that PGE2, 8-BrcAMP, and cholera toxin inhibited K+ channel activity. For instance, the amplitude of the outward K+ current was reduced to 43 ± 19%, 50 ± 26%, and 46 ± 16% of control values in the case of cells perfused in the presence of PGE2, 8-BrcAMP, and cholera toxin, respectively. Blocking K+ channels with tetraethylammonium ions did not prevent the characteristic Jurkat Ca2+ response to PHA. Our observations that cAMP inhibits K+ channel activity in a T cell line provide an additional explanation for its reported inhibition of lymphocyte activation. Increasing the intracellular concentration of cAMP may result in reduction of K+ movements and in negative modulation of signal transduction via G-proteins as previously suggested. These two effects could act in synergy to impair signal transduction.

References (64)

  • N. Isakov et al.

    Immunol. Today

    (1986)
  • T.R. Hesketh et al.

    J. Biol. Chem

    (1983)
  • A. Weiss et al.

    Adv. Immunol

    (1987)
  • J.J. Oppenheim et al.

    Immunol. Today

    (1986)
  • J.E. Dumont et al.

    Trends Biochem. Sci

    (1989)
  • J. Iwaz et al.

    Cell. Immunol

    (1986)
  • L.E. Averill et al.

    Cell. Immunol

    (1988)
  • A. Novogrodsky et al.

    Biochem. Biophys. Res. Commun

    (1983)
  • G. Grynkiewicz et al.

    J. Biol. Chem

    (1985)
  • I.B. Levitan

    J. Membr. Biol

    (1985)
  • B. Soliven et al.

    J. Memb. Biol

    (1988)
  • J.P. Allison et al.

    Annu. Rev. Immunol

    (1987)
  • J. Forman

    Immunol. Rev

    (1984)
  • P. Marrack et al.

    Science

    (1987)
  • D.C. Linch et al.

    Immunol. Rev

    (1987)
  • E.R. Unanue et al.

    Science

    (1987)
  • A. Alcover et al.

    Immunol. Rev

    (1987)
  • G. Pantaleo et al.

    Eur. J. Immunol

    (1986)
  • J.B. Imboden et al.

    Biochem. J

    (1987)
  • H.R. MacDonald et al.

    Annu. Rev. Cell Biol

    (1986)
  • K. O'Flynn et al.

    Biochem. J

    (1984)
  • E.W. Gelfand et al.

    Immunol. Rev

    (1987)
  • R.Y. Tsien et al.

    Nature (London)

    (1982)
  • M.J. Berridge et al.

    Nature (London)

    (1984)
  • N. Isakov et al.

    Immunol. Rev

    (1987)
  • Y. Nishizuka

    Nature (London)

    (1984)
  • N. Isakov et al.

    J. Immunol

    (1987)
  • M. Hatakeyama et al.

    Science

    (1989)
  • K.A. Smith

    Science

    (1988)
  • T.E. DeCoursey et al.

    Nature (London)

    (1984)
  • T.E. Deutsch et al.

    Biochim. Biophys. Acta

    (1982)
  • J.G. Kaplan

    Annu. Rev. Physiol

    (1978)
  • Cited by (0)

    View full text